Fiuzat, M., Nordenberg, T. S., Zeller, M., Hillebrenner, M. G., Stockbridge, N., Zuckerman, B., & Califf, R. M. (2017). FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention. JACC Heart Fail, 5(2), 152–153. https://doi.org/10.1016/j.jchf.2016.11.010

Fiuzat, Mona, Tamar S. Nordenberg, Mitchell Zeller, Matthew G. Hillebrenner, Norman Stockbridge, Bram Zuckerman, and Robert M. Califf. “FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention.” JACC Heart Fail 5, no. 2 (February 2017): 152–53. https://doi.org/10.1016/j.jchf.2016.11.010.

Fiuzat M, Nordenberg TS, Zeller M, Hillebrenner MG, Stockbridge N, Zuckerman B, et al. FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention. JACC Heart Fail. 2017 Feb;5(2):152–3.

Fiuzat, Mona, et al. “FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention.” JACC Heart Fail, vol. 5, no. 2, Feb. 2017, pp. 152–53. Pubmed, doi:10.1016/j.jchf.2016.11.010.

Fiuzat M, Nordenberg TS, Zeller M, Hillebrenner MG, Stockbridge N, Zuckerman B, Califf RM. FDA in the 21st Century: Focus on Tobacco Policies and Heart Failure Prevention. JACC Heart Fail. 2017 Feb;5(2):152–153.